ToolGen, mCureX team up for mRNA-based gene therapy for rare eye disorders

2022.06.14 13:49:52

[Source: ToolGen]이미지 확대

[Source: ToolGen]

ToolGen has forged a partnership with mCureX for joint research and development of an mRNA-based gene therapy for rare eye disorders. The two companies will leverage the combination of ToolGen’s gene-editing solution and mCureX’s mRNA technology to develop a treatment for rare hereditary eye diseases.

[ⓒ Pulse by Maeil Business Newspaper & mk.co.kr, All rights reserved]